The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Sign Up to like & getrecommendations! Published in 2018 at "European urology oncology"
DOI: 10.1016/j.euo.2018.03.007
Abstract: BACKGROUND African American (AA) men might be less likely to benefit from certain treatment types for localized prostate cancer (PCa). OBJECTIVE To test treatment rate differences between AA and Caucasian patients with clinically localized PCa,… read more here.
Keywords: risk; adjustment; ocm; treatment ... See more keywords
Impact of the Oncology Care Model (OCM) on pain management: A retrospective cohort analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.31_suppl.86
Abstract: 86 Background: Pain is a common symptom among patients with cancer and impacts performance status and quality of life. The OCM was implemented at Rutgers Cancer Institute of New Jersey (RCINJ) in July 2016 with… read more here.
Keywords: plan care; ocm; pain; oncology ... See more keywords
Deletion of Oncomodulin Gives Rise to Early Progressive Cochlear Dysfunction in C57 and CBA Mice
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2021.749729
Abstract: Ca2+ signaling is a major contributor to sensory hair cell function in the cochlea. Oncomodulin (OCM) is a Ca2+ binding protein (CaBP) preferentially expressed in outer hair cells (OHCs) of the cochlea and few other… read more here.
Keywords: hearing; mice; early progressive; loss ... See more keywords